BioFluidica to Commericalize LiquidScan Biopsy System
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.
Read MorePosted by Toni Mitchell | Sep 21, 2021 | Leukemia, Microbiology Instruments, Prenatal Testing |
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.
Read MorePosted by Chris Wolski | Sep 8, 2021 | Molecular Diagnostic Analyzers |
Mission Bio has announced two key improvements to the core capabilities of its Tapestri Platform for hematologic oncology (heme-onc) research.
Read MorePosted by Melanie Hamilton-Basich | Jul 27, 2021 | Cancer |
St. Jude Children’s Research Hospital investigators have demonstrated that comprehensive genomic sequencing of all pediatric cancer patients is feasible and essential to capitalize on the lifesaving potential of precision medicine.
Read MorePosted by Chris Wolski | Jul 12, 2021 | Covid 19 |
Through much of 2020, SARS-CoV-2 accumulated mutations at a slow and steady rate, but more variants have emerged with new pathogenic traits.
Read MorePosted by Chris Wolski | Jun 24, 2021 | Company News |
A trio of cutting-edge companies have announced a collaboration that will enable nearly instant medical test results.
Read More